Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SLIT2 promoter hypermethylation-mediated SLIT2-IT1/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasm

29 Jul 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Cancer-related molecular mechanisms research
Share to Epigenetics and DNA Methylation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35906386
DOI: 10.1038/s41375-022-01659-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SLIT2 promoter hypermethylation-mediated SLIT2-IT1/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasmPMID 35906386Read ↗

SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemiaSemantic proximity Read ↗

Analysis of core mutation and TET2/ASXL1 mutations DNA methylation profile in myelodysplastic syndrome.Semantic proximity Read ↗

ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndromeSemantic proximity Read ↗

Acquired mutations in TET2 are common in myelodysplastic syndromes.Semantic proximity Read ↗

TET2 mutations in myelodysplasia and myeloid malignancies.Semantic proximity Read ↗

Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformationSemantic proximity Read ↗

TET2 Mutation and High miR-22 Expression as Biomarkers to Predict Clinical Outcome in Myelodysplastic Syndrome Patients Treated with Hypomethylating Therapy.Semantic proximity Read ↗

Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice.Semantic proximity Read ↗

Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155Semantic proximity Read ↗

Ten-eleven-translocation 2 (TET2) is downregulated in myelodysplastic syndromes.Semantic proximity Read ↗

Prognostic significance of TET2 mutations in myelodysplastic syndromes: A meta-analysis.Semantic proximity Read ↗

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.